FDA
FDA Determines Pralidoxime Chloride Autoinjector Was Not Withdrawn for Safety or Effectiveness Reasons
According to an FDA statement, the agency has concluded that the pralidoxime chloride autoinjector (600 mg/2 mL) was not removed from the market due to safety or effectiveness concerns, which would permit approval of…
1 source2 claims checked9h ago
2 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis